UK Parkinson
UK Parkinson
UK Parkinson's Disease Consortium
Verified email at ucl.ac.uk - Homepage
TitleCited byYear
A Hexanucleotide Repeat Expansion in< i> C9ORF72</i> Is the Cause of Chromosome 9p21-Linked ALS-FTD
AE Renton, E Majounie, A Waite, J Simón-Sánchez, S Rollinson, ...
Neuron 72 (2), 257-268, 2011
26972011
TREM2 variants in Alzheimer's disease
R Guerreiro, A Wojtas, J Bras, M Carrasquillo, E Rogaeva, E Majounie, ...
New England Journal of Medicine, 2012
14522012
Mitochondrial diseases
AHV Schapira
The Lancet, 2012
985*2012
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ...
Nature genetics 46 (9), 989, 2014
9102014
Frequency of the< i> C9orf72</i> hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
E Majounie, AE Renton, K Mok, EGP Dopper, A Waite, S Rollinson, ...
The Lancet Neurology, 2012
7172012
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.
MA Nalls, V Plagnol, DG Hernandez, M Sharma, UM Sheerin, M Saad, ...
Lancet 377 (9766), 641, 2011
7062011
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
ME Gegg, JM Cooper, KY Chau, M Rojo, AHV Schapira, JW Taanman
Human molecular genetics 19 (24), 4861-4870, 2010
6602010
Mechanism of Oxidative Stress in Neurodegeneration
S Gandhi, AY Abramov
Oxidative Medicine and Cellular Longevity 2012, 2012
5012012
Direct observation of the interconversion of normal and toxic forms of α-synuclein
N Cremades, SIA Cohen, E Deas, AY Abramov, AY Chen, A Orte, ...
Cell 149 (5), 1048-1059, 2012
4752012
Etiology and pathogenesis of Parkinson's disease
AH Schapira, P Jenner
Movement Disorders 26 (6), 1049-1055, 2011
4722011
PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65
C Kondapalli, A Kazlauskaite, N Zhang, HI Woodroof, DG Campbell, ...
Open Biology 2 (5), 2012
4162012
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
L Alvarez-Erviti, Y Seow, AH Schapira, C Gardiner, IL Sargent, MJA Wood, ...
Neurobiology of disease 42 (3), 360-367, 2011
3902011
Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
A Kazlauskaite, C Kondapalli, R Gourlay, DG Campbell, MS Ritorto, ...
Biochemical Journal 460 (1), 127-141, 2014
3812014
Priorities in Parkinson's disease research
WG Meissner, M Frasier, T Gasser, CG Goetz, A Lozano, P Piccini, ...
Nature reviews Drug discovery 10 (5), 377, 2011
3752011
Lewy-and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Y Compta, L Parkkinen, SS O'Sullivan, J Vandrovcova, JL Holton, ...
Brain 134 (5), 1493-1505, 2011
3692011
Chaperone-mediated autophagy markers in Parkinson disease brains
L Alvarez-Erviti, MC Rodriguez-Oroz, JM Cooper, C Caballero, I Ferrer, ...
Archives of neurology 67 (12), 1464-1472, 2010
3432010
Genetic variability in the regulation of gene expression in ten regions of the human brain
A Ramasamy, D Trabzuni, S Guelfi, V Varghese, C Smith, R Walker, T De, ...
Nature neuroscience 17 (10), 1418, 2014
3322014
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
MJ Devine, M Ryten, P Vodicka, AJ Thomson, T Burdon, H Houlden, ...
Nature communications 2, 440, 2011
3222011
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
C Cruchaga, CM Karch, SC Jin, BA Benitez, Y Cai, R Guerreiro, O Harari, ...
Nature 505 (7484), 550, 2014
3192014
A novel α-synuclein missense mutation in Parkinson disease
C Proukakis, CG Dudzik, T Brier, DS MacKay, JM Cooper, GL Millhauser, ...
Neurology 80 (11), 1062-1064, 2013
3072013
The system can't perform the operation now. Try again later.
Articles 1–20